Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: British Journal of Cancer, 79, 7-8, S. 1182-1184
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg, Springer Science and Business Media LLC
- (when)
-
1999
- Creator
-
Wittke, F.
Hoffmann, Reinhard
Buer, J.
Dallmann, I.
Oevermann, K.
Sel, S.
Wandert, T.
Ganser, A.
Atzpodien, J.
- DOI
-
10.1038/sj.bjc.6690189
- URN
-
urn:nbn:de:bvb:384-opus4-782380
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wittke, F.
- Hoffmann, Reinhard
- Buer, J.
- Dallmann, I.
- Oevermann, K.
- Sel, S.
- Wandert, T.
- Ganser, A.
- Atzpodien, J.
- Universität Augsburg, Springer Science and Business Media LLC
Time of origin
- 1999
Other Objects (12)
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice
Early detection of the immunophenotyping after conversion to belatacept in comparison to conventional immunosuppressive therapy in renal transplant patients
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice
Early detection of the immunophenotyping after conversion to belatacept in comparison to conventional immunosuppressive therapy in renal transplant patients
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice